Sequent Scientific Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | 39.10 | 24 | 12.80 | 36.80 |
| Op profit growth | 105 | 93.20 | (22) | 205 |
| EBIT growth | 123 | 317 | (39) | (719) |
| Net profit growth | (83) | (3,150) | (25) | 72 |
| Profitability ratios (%) | ||||
| OPM | 14.40 | 9.79 | 6.28 | 9.10 |
| EBIT margin | 11 | 6.87 | 2.04 | 3.75 |
| Net profit margin | 5.93 | 49.70 | (2) | (3) |
| RoCE | 12.20 | 4.81 | 1.04 | 2.30 |
| RoNW | 2.51 | 13 | (0.40) | (0.90) |
| RoA | 1.64 | 8.71 | (0.30) | (0.50) |
| Per share ratios () | ||||
| EPS | 3.30 | 17.70 | -- | -- |
| Dividend per share | -- | 0.20 | -- | -- |
| Cash EPS | 0.78 | 15.60 | (2.20) | (2.70) |
| Book value per share | 29.90 | 26.60 | 40.10 | 39.70 |
| Valuation ratios | ||||
| P/E | 23.50 | 4.05 | -- | -- |
| P/CEPS | 100 | 4.58 | (54) | (50) |
| P/B | 2.60 | 2.69 | 2.97 | 3.41 |
| EV/EBIDTA | 12.10 | 21.60 | 65 | 55.10 |
| Payout (%) | ||||
| Dividend payout | -- | 1.15 | -- | -- |
| Tax payout | (13) | (54) | (3.70) | 16.70 |
| Liquidity ratios | ||||
| Debtor days | 89.30 | 110 | 119 | 92.70 |
| Inventory days | 58.50 | 68.70 | 79 | 69.10 |
| Creditor days | (70) | (90) | (103) | (84) |
| Leverage ratios | ||||
| Interest coverage | (3.60) | (1.80) | (0.50) | (0.60) |
| Net debt / equity | 0.34 | 0.40 | 0.38 | 0.30 |
| Net debt / op. profit | 1.50 | 3.16 | 8.58 | 5.20 |
| Cost breakup () | ||||
| Material costs | (51) | (55) | (52) | (49) |
| Employee costs | (14) | (13) | (16) | (14) |
| Other costs | (20) | (22) | (26) | (27) |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Revenue | 1,179 | 848 | 684 | 606 |
| yoy growth (%) | 39.10 | 24 | 12.80 | 36.80 |
| Raw materials | (605) | (462) | (357) | (300) |
| As % of sales | 51.30 | 54.50 | 52.20 | 49.50 |
| Employee costs | (165) | (114) | (106) | (87) |
| As % of sales | 14 | 13.40 | 15.50 | 14.30 |
| Other costs | (239) | (189) | (178) | (165) |
| As % of sales | 20.30 | 22.20 | 26 | 27.10 |
| Operating profit | 170 | 83 | 42.90 | 55.20 |
| OPM | 14.40 | 9.79 | 6.28 | 9.10 |
| Depreciation | (51) | (41) | (40) | (46) |
| Interest expense | (36) | (33) | (28) | (38) |
| Other income | 10.10 | 16.60 | 11.10 | 13.30 |
| Profit before tax | 94.10 | 25.10 | (14) | (15) |
| Taxes | (12) | (13) | 0.53 | (2.60) |
| Tax rate | (13) | (54) | (3.70) | 16.70 |
| Minorities and other | (12) | 411 | 0.04 | (0.50) |
| Adj. profit | 69.90 | 423 | (14) | (18) |
| Exceptional items | -- | (1.50) | -- | -- |
| Net profit | 69.90 | 422 | (14) | (18) |
| yoy growth (%) | (83) | (3,150) | (25) | 72 |
| NPM | 5.93 | 49.70 | (2) | (3) |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|
| Profit before tax | 94.10 | 25.10 | (14) | (15) |
| Depreciation | (51) | (41) | (40) | (46) |
| Tax paid | (12) | (13) | 0.53 | (2.60) |
| Working capital | 320 | 222 | 192 | 107 |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | 352 | 193 | 138 | 42.80 |
| Capital expenditure | 554 | 277 | 459 | 275 |
| Free cash flow | 906 | 469 | 597 | 317 |
| Equity raised | 753 | 311 | 1,039 | 967 |
| Investments | 171 | 239 | 426 | 427 |
| Debt financing/disposal | 231 | 128 | 184 | 203 |
| Dividends paid | -- | 4.85 | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 2,061 | 1,152 | 2,246 | 1,916 |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 49.70 | 49.40 | 48.80 | 48.80 |
| Preference capital | -- | -- | -- | -- |
| Reserves | 693 | 657 | 599 | 928 |
| Net worth | 743 | 707 | 648 | 977 |
| Minority interest | ||||
| Debt | 331 | 325 | 305 | 416 |
| Deferred tax liabilities (net) | 8.61 | 10.30 | 10.80 | 8.89 |
| Total liabilities | 1,127 | 1,082 | 1,000 | 1,419 |
| Fixed assets | 646 | 521 | 494 | 717 |
| Intangible assets | ||||
| Investments | 171 | 180 | 239 | 428 |
| Deferred tax asset (net) | 23.50 | 14.30 | 21.20 | 21.10 |
| Net working capital | 210 | 295 | 203 | 205 |
| Inventories | 219 | 200 | 159 | 161 |
| Inventory Days | 67.90 | -- | 68.30 | 85.90 |
| Sundry debtors | 319 | 278 | 258 | 255 |
| Debtor days | 98.70 | -- | 111 | 136 |
| Other current assets | 63.90 | 122 | 129 | 276 |
| Sundry creditors | (224) | (213) | (165) | (211) |
| Creditor days | 69.50 | -- | 70.90 | 112 |
| Other current liabilities | (167) | (93) | (178) | (275) |
| Cash | 75.80 | 72 | 42.50 | 47.40 |
| Total assets | 1,127 | 1,082 | 1,000 | 1,419 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 | Mar-2016 |
|---|---|---|---|---|---|
| Gross Sales | 1,179 | 1,039 | 849 | 689 | 621 |
| Excise Duty | -- | -- | 1.61 | 5.44 | 15.20 |
| Net Sales | 1,179 | 1,039 | 848 | 684 | 606 |
| Other Operating Income | -- | -- | -- | -- | -- |
| Other Income | 10.10 | 8.67 | 447 | 11.10 | 14.90 |
| Total Income | 1,189 | 1,048 | 1,294 | 695 | 621 |
| Total Expenditure ** | 1,009 | 914 | 776 | 643 | 551 |
| PBIDT | 180 | 134 | 519 | 51.50 | 70.10 |
| Interest | 35.70 | 32.80 | 33.10 | 28.30 | 38.20 |
| PBDT | 145 | 101 | 486 | 23.20 | 31.90 |
| Depreciation | 50.60 | 41.90 | 41.30 | 40.10 | 45.70 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 22.50 | (4) | 14.80 | 3.24 | 2.94 |
| Deferred Tax | (10) | 5.98 | (1.30) | (3.80) | (0.40) |
| Reported Profit After Tax | 82.10 | 56.90 | 431 | (16) | (16) |
| Minority Interest After NP | 12.10 | 8.22 | 9.26 | (2.60) | -- |
| Net Profit after Minority Interest | 69.90 | 48.70 | 422 | (14) | (16) |
| Extra-ordinary Items | -- | -- | 408 | -- | -- |
| Adjusted Profit After Extra-ordinary item | 69.90 | 48.70 | 13.90 | (14) | (16) |
| EPS (Unit Curr.) | 2.87 | 2 | (0.10) | (0.60) | (0.90) |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | 10 | 10 | -- | -- |
| Equity | 49.70 | 49.40 | 48.80 | 48.80 | 47.70 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 15.30 | 12.90 | 61.20 | 7.53 | 11.60 |
| PBDTM(%) | 12.30 | 9.70 | 57.30 | 3.39 | 5.26 |
| PATM(%) | 6.96 | 5.47 | 50.80 | (2.40) | (2.70) |
